An Update on Neurotoxicity After Cellular Therapies

Date/Time: Monday, October 24, 2022 - 12:00 PM – 1:00 PM
Track: Interactive Lunch Workshop
Log in to Add to My Schedule


Neurotoxicity associated with cellular therapies is an often devastating complication seen in patients undergoing treatment for an ever growing range of cancers. Yet who is most at risk remains unclear. This session examines different potential mechanisms underlying this disorder and as well as explore its long-term side effects. 

Chair: Thomas E. Lloyd, MD, PhD, FANA

Co-Chair: Matthew Frank, MD, PhD

Introduction to Session and Neurotoxicity of Cellular Therapies


Understanding Patients Factors Associated with Neurotoxicity After Cellular Therapies


Pre-Infusion NfL as a blood Biomarker for the Development of Neurotoxicity after Cellular Therapy



The Blood Brain Barrier and Neurotoxicity After Cellular Therapies